$APCX
AppTech Payments Corp.

2023 Q2 Form 10-Q Financial Statement

#000168316823003031 Filed on May 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $134.0K $89.00K $108.0K
YoY Change 8.94% -14.42% 13.52%
Cost Of Revenue $62.00K $53.00K $53.00K
YoY Change 0.0% 3.92% 41.64%
Gross Profit $72.00K $36.00K $55.00K
YoY Change 18.03% -32.08% -4.71%
Gross Profit Margin 53.73% 40.45% 50.93%
Selling, General & Admin $2.816M $2.073M $2.537M
YoY Change 113.33% -25.4% 52.3%
% of Gross Profit 3911.11% 5758.33% 4612.73%
Research & Development $498.0K $1.525M $2.018M
YoY Change -82.73% -25.72% 1093.87%
% of Gross Profit 691.67% 4236.11% 3669.09%
Depreciation & Amortization $293.0K $293.0K $405.0K
YoY Change
% of Gross Profit 406.94% 813.89% 736.36%
Operating Expenses $9.445M $3.598M $4.555M
YoY Change 120.88% -36.48% -2.38%
Operating Profit -$9.373M -$3.562M -$4.500M
YoY Change 122.37% -36.52% -2.35%
Interest Expense $3.000K $46.00K -$295.0K
YoY Change -92.68% -43.21% 65.64%
% of Operating Profit
Other Income/Expense, Net $290.0K $411.0K $35.00K
YoY Change 229.55% 448.0% -96.62%
Pretax Income -$9.083M -$3.151M -$4.760M
YoY Change 120.09% -42.24% 26.89%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$9.083M -$3.151M -$4.760M
YoY Change 120.09% -42.24% 26.89%
Net Earnings / Revenue -6778.36% -3540.45% -4407.41%
Basic Earnings Per Share -$0.49 -$0.22
Diluted Earnings Per Share -$0.49 -$0.22 -$0.29
COMMON SHARES
Basic Shares Outstanding 18.54M shares 18.44M shares 16.41M shares
Diluted Shares Outstanding 18.47M shares 17.85M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $749.0K $2.067M $3.462M
YoY Change -90.39% -79.91% 43013.33%
Cash & Equivalents $749.0K $2.067M $3.462K
Short-Term Investments
Other Short-Term Assets $333.0K $2.645M $912.0K
YoY Change -64.76% 212.65% 58.81%
Inventory
Prepaid Expenses $333.0K $589.0K $183.00
Receivables $442.0K $63.00K $51.00
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.524M $4.775M $4.425K
YoY Change -82.65% -57.29% -99.29%
LONG-TERM ASSETS
Property, Plant & Equipment $97.00K $112.0K $127.0K
YoY Change -38.61% -35.26% -32.68%
Goodwill $0.00
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $9.000K $2.529M $2.709M
YoY Change -99.72% -17.57% -17.4%
Total Long-Term Assets $1.706M $7.606M $8.094K
YoY Change -76.96% 10.36% -99.88%
TOTAL ASSETS
Total Short-Term Assets $1.524M $4.775M $4.425K
Total Long-Term Assets $1.706M $7.606M $8.094K
Total Assets $3.230M $12.38M $12.52K
YoY Change -80.05% -31.49% -99.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $478.0K $461.0K $347.00
YoY Change 21.32% -2.74% -99.97%
Accrued Expenses $578.0K $1.163M $1.870K
YoY Change -64.99% -38.3% -99.94%
Deferred Revenue
YoY Change
Short-Term Debt $1.000K $281.0K $1.785M
YoY Change -99.94% -84.09% -0.9%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.525M $2.377M $4.929K
YoY Change -67.89% -52.63% -99.93%
LONG-TERM LIABILITIES
Long-Term Debt $67.00K $67.00K $67.00K
YoY Change 0.0% 0.0% -0.59%
Other Long-Term Liabilities $51.00K $80.00K $99.00K
YoY Change -61.07% -96.47% -39.3%
Total Long-Term Liabilities $118.0K $147.0K $166.00
YoY Change -40.4% -93.7% -99.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.525M $2.377M $4.929K
Total Long-Term Liabilities $118.0K $147.0K $166.00
Total Liabilities $1.643M $2.524M $5.095K
YoY Change -66.79% -65.67% -99.93%
SHAREHOLDERS EQUITY
Retained Earnings -$153.5M -$144.4M $140.5K
YoY Change 14.72% -100.11%
Common Stock $19.00K $19.00K $17.00
YoY Change 18.75% -99.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.587M $9.857M $7.424K
YoY Change
Total Liabilities & Shareholders Equity $3.230M $12.38M $12.52K
YoY Change -80.05% -31.49% -99.83%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$9.083M -$3.151M -$4.760M
YoY Change 120.09% -42.24% 26.89%
Depreciation, Depletion And Amortization $293.0K $293.0K $405.0K
YoY Change
Cash From Operating Activities -$2.366M -$3.050M -$2.452M
YoY Change -5.36% 5.98% 144.3%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $41.00K
YoY Change -100.0% -89.51%
Acquisitions
YoY Change
Other Investing Activities -$2.000K
YoY Change
Cash From Investing Activities $0.00 $0.00 -$43.00K
YoY Change -100.0% -111.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -279.0K $2.982M 79.00K
YoY Change -77.65% -86.8%
NET CHANGE
Cash From Operating Activities -2.366M -$3.050M -2.452M
Cash From Investing Activities 0.000 $0.00 -43.00K
Cash From Financing Activities -279.0K $2.982M 79.00K
Net Change In Cash -2.645M -$68.00K -2.416M
YoY Change 5.8% -100.66% 16596.61%
FREE CASH FLOW
Cash From Operating Activities -$2.366M -$3.050M -$2.452M
Capital Expenditures $0.00 $0.00 $41.00K
Free Cash Flow -$2.366M -$3.050M -$2.493M
YoY Change -5.36% 13.26% 78.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 apcx Prepaid License Fees Current
PrepaidLicenseFeesCurrent
729000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
4775000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
4425000 usd
CY2023Q1 us-gaap Prepaid Expense Other Noncurrent
PrepaidExpenseOtherNoncurrent
2520000 usd
CY2022Q4 us-gaap Prepaid Expense Other Noncurrent
PrepaidExpenseOtherNoncurrent
2700000 usd
CY2023Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
277000 usd
CY2022Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
311000 usd
CY2023Q1 apcx Note Receivable Current
NoteReceivableCurrent
26000 usd
CY2022Q4 apcx Note Receivable Current
NoteReceivableCurrent
26000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
112000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
127000 usd
CY2023Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
9000 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
9000 usd
CY2023Q1 apcx Capitalized Software Development And License Net Of Accumulated Amortization
CapitalizedSoftwareDevelopmentAndLicenseNetOfAccumulatedAmortization
4662000 usd
CY2022Q4 apcx Capitalized Software Development And License Net Of Accumulated Amortization
CapitalizedSoftwareDevelopmentAndLicenseNetOfAccumulatedAmortization
4921000 usd
CY2023Q1 us-gaap Assets
Assets
12381000 usd
CY2022Q4 us-gaap Assets
Assets
12519000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
461000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
347000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1163000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1870000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
66000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
64000 usd
CY2023Q1 apcx Stock Repurchase Liability
StockRepurchaseLiability
0 usd
CY2022Q4 apcx Stock Repurchase Liability
StockRepurchaseLiability
430000 usd
CY2023Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
0 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
4000 usd
CY2023Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
280000 usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
676000 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
1000 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1021000 usd
CY2023Q1 apcx Notes Payable Related Parties
NotesPayableRelatedParties
0 usd
CY2022Q4 apcx Notes Payable Related Parties
NotesPayableRelatedParties
88000 usd
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
406000 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
433000 usd
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001070050
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1525000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2053000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
293000 usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-27569
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
AppTech Payments Corp.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
65-0847995
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
5876 Owens Ave. Suite 100
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Carlsbad
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92008
CY2023Q1 dei City Area Code
CityAreaCode
(760)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
707-5959
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18542697 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2067000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3462000 usd
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
1327000 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
63000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
51000 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
589000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
183000 usd
CY2023Q1 apcx Prepaid License Fees Current
PrepaidLicenseFeesCurrent
729000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2377000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4929000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
80000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
99000 usd
CY2023Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
67000 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
67000 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
147000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
166000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
2524000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
5095000 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10526 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10526 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
14 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
14 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
14 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
14 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
105263158 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
105263158 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18542697 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18542697 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16697280 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16697280 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
19000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
17000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
154226000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
147881000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-144388000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-140474000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
9857000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7424000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12381000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12519000 usd
CY2023Q1 us-gaap Revenues
Revenues
89000 usd
CY2022Q1 us-gaap Revenues
Revenues
104000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
53000 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
51000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
36000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
53000 usd
CY2023Q1 apcx Stock Based Compensation Including Selling General And Administrative
StockBasedCompensationIncludingSellingGeneralAndAdministrative
232000 usd
CY2022Q1 apcx Stock Based Compensation Including Selling General And Administrative
StockBasedCompensationIncludingSellingGeneralAndAdministrative
2508000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2073000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2779000 usd
CY2023Q1 apcx Stock Based Compensation Including Research And Development
StockBasedCompensationIncludingResearchAndDevelopment
628000 usd
CY2022Q1 apcx Stock Based Compensation Including Research And Development
StockBasedCompensationIncludingResearchAndDevelopment
0 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1525000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2053000 usd
CY2023Q1 apcx Excess Fair Value Of Equity Issuance Over Assets Received
ExcessFairValueOfEquityIssuanceOverAssetsReceived
0 usd
CY2022Q1 apcx Excess Fair Value Of Equity Issuance Over Assets Received
ExcessFairValueOfEquityIssuanceOverAssetsReceived
832000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
3598000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
5664000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3562000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5611000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
46000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
55000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
27000 usd
CY2022Q1 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
136000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
430000 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
75000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
411000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
156000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3151000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5455000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3151000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5455000 usd
CY2023Q1 us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
763000 usd
CY2022Q1 us-gaap Other Preferred Stock Dividends And Adjustments
OtherPreferredStockDividendsAndAdjustments
-0 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3914000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5455000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17847780 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17847780 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15470497 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15470497 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
44000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5455000 usd
CY2022Q1 apcx Common Stock Issued For Forbearance Amount
CommonStockIssuedForForbearanceAmount
3000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2732000 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
13395000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
10719000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7424000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3151000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
860000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
234000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
0 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4490000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
9857000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3151000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5455000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
860000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2508000 usd
CY2023Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
CY2022Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
156000 usd
CY2023Q1 apcx Common Stock Issued For Forbearances Two
CommonStockIssuedForForbearancesTwo
-0 usd
CY2022Q1 apcx Common Stock Issued For Forbearances Two
CommonStockIssuedForForbearancesTwo
-3000 usd
CY2023Q1 apcx Cancellation Of Stock Repurchase Liabilities
CancellationOfStockRepurchaseLiabilities
430000 usd
CY2022Q1 apcx Cancellation Of Stock Repurchase Liabilities
CancellationOfStockRepurchaseLiabilities
-0 usd
CY2023Q1 apcx Stock Issued For Excess Fair Value Of Equity Over Assets Received
StockIssuedForExcessFairValueOfEquityOverAssetsReceived
0 usd
CY2022Q1 apcx Stock Issued For Excess Fair Value Of Equity Over Assets Received
StockIssuedForExcessFairValueOfEquityOverAssetsReceived
832000 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
4000 usd
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
14000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
293000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2023Q1 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-27000 usd
CY2022Q1 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-136000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
173000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-8000 usd
CY2023Q1 apcx Increase Decrease In Prepaid License Costs
IncreaseDecreaseInPrepaidLicenseCosts
180000 usd
CY2022Q1 apcx Increase Decrease In Prepaid License Costs
IncreaseDecreaseInPrepaidLicenseCosts
0 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
114000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-781000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-706000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-25000 usd
CY2023Q1 apcx Increase Decrease Right Of Use Asset And Liability
IncreaseDecreaseRightOfUseAssetAndLiability
-2000 usd
CY2022Q1 apcx Increase Decrease Right Of Use Asset And Liability
IncreaseDecreaseRightOfUseAssetAndLiability
1000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3050000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2878000 usd
CY2023Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
-0 usd
CY2022Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
185000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-185000 usd
CY2023Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
88000 usd
CY2022Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
-0 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1020000 usd
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
50000 usd
CY2023Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
400000 usd
CY2022Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
-0 usd
CY2023Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
4490000 usd
CY2022Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
13395000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2982000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13345000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-68000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
10282000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3462000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3394000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10290000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
967000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 apcx Cancellation Of Stock Repurchase Liability
CancellationOfStockRepurchaseLiability
-430000 usd
CY2022Q1 apcx Cancellation Of Stock Repurchase Liability
CancellationOfStockRepurchaseLiability
-0 usd
CY2023Q1 apcx Issuance Of Stock For Prepaid Service
IssuanceOfStockForPrepaidService
234000 usd
CY2022Q1 apcx Issuance Of Stock For Prepaid Service
IssuanceOfStockForPrepaidService
156000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2067000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10290000 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
1327000 usd
CY2022Q1 us-gaap Restricted Cash
RestrictedCash
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3394000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10290000 usd
CY2021Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
9.5 to 1
CY2021Q4 apcx Sale Of Stock Units
SaleOfStockUnits
4.15
CY2023Q2 apcx Remaining Amount For Shelf Registration
RemainingAmountForShelfRegistration
70000000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
531000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_848_eus-gaap--UseOfEstimates_zKhRsP8heWGe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_86C_zw8uvRsfbhmb">Use of Estimates</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the estimated liabilities related to various vendors in which communications have ceased, contingent liabilities, valuation of the derivative liabilities, and realization of tax deferred tax assets. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
1327000 usd
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_z1rTvXI1tIP" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration: underline"><span id="xdx_864_zTPv6jACRtI8">Concentration of Credit Risk</span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash and cash equivalents are maintained at financial institutions and, at times, balances may exceed federally insured limits of $250,000 per institution that pays Federal Deposit Insurance Corporation (“FDIC”) insurance premiums. The Company has never experienced any losses related to these balances.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accounts receivable from merchant services are paid by the financial institutions on a monthly basis. There is no merchant (customer) representing a significant amount of total revenue, for the three months ended March 31, 2023 and for the year ended December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
311000 usd
CY2023Q1 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
406000 usd
CY2022Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
433000 usd
CY2023Q1 apcx Diluted Income Per Share
DilutedIncomePerShare
7892314000 shares
CY2022Q1 apcx Diluted Income Per Share
DilutedIncomePerShare
6006350000 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7892314000 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6006350000 shares
CY2022Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
5200000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
499000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1436000 usd
CY2023Q1 apcx Accrued Residuals Current
AccruedResidualsCurrent
30000 usd
CY2022Q4 apcx Accrued Residuals Current
AccruedResidualsCurrent
31000 usd
CY2023Q1 apcx Antidilution Provision Payable Current
AntidilutionProvisionPayableCurrent
72000 usd
CY2022Q4 apcx Antidilution Provision Payable Current
AntidilutionProvisionPayableCurrent
72000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
31000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
20000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1163000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1870000 usd
CY2023Q1 apcx Derivative Loss On Derivative1
DerivativeLossOnDerivative1
390000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-27000 usd
CY2022 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
166000 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
433000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-27000 usd
CY2023Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
406000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
66000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
90000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
8000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
164000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
18000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
146000 usd
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
18000 usd
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
15000 usd
CY2023Q2 apcx Remaining Amount For Shelf Registration
RemainingAmountForShelfRegistration
70000000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1089868000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.00
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y10M28D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
16447000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.38
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1073421000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.07
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y9M18D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
779892000 shares
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
7.14
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P1Y9M18D
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
690000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
115000 usd
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5942388 shares

Files In Submission

Name View Source Status
0001683168-23-003031-index-headers.html Edgar Link pending
0001683168-23-003031-index.html Edgar Link pending
0001683168-23-003031.txt Edgar Link pending
0001683168-23-003031-xbrl.zip Edgar Link pending
apcx-20230331.xsd Edgar Link pending
apcx-20230331_cal.xml Edgar Link unprocessable
apcx-20230331_def.xml Edgar Link unprocessable
apptech_ex3101.htm Edgar Link pending
apptech_ex3102.htm Edgar Link pending
apptech_ex3201.htm Edgar Link pending
apptech_ex3202.htm Edgar Link pending
apptech_i10q-033123.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
apcx-20230331_pre.xml Edgar Link unprocessable
apcx-20230331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
apptech_i10q-033123_htm.xml Edgar Link completed